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Background/Purpose: Early detection and intervention of psychosis is clinically important. This study
aimed to test the applicability of the Chinese version of the Prodromal Questionnaire (CPQ) for identify-
ing prodromal states of psychosis.
Methods: This is a two-group cross-sectional comparative study. The Prodromal Questionnaire (PQ) was
translated into traditional Chinese based on Brislin’s Revised Model. Like the PQ, the CPQ provides re-
sults on four subscales: (1) positive symptoms, (2) negative symptoms, (3) disorganized symptoms, and
(4) general symptoms. An expert panel of five senior psychiatrists established the content validity of the
CPQ. The experimental group was a sample of 100 first-visit patients to a psychiatric outpatient depart-
ment (FVPOD). The comparison group comprised 98 nursing students without any history of psychiatric
disturbances. Both the CPQ and the Chinese Health Questionnaire-12 were administered to all 198 sub-
jects. Clinical psychosis was assessed using the Chinese version of the Diagnostic Interview for Genetic
Studies, and 30 of the 100 FVPOD subjects were thus identified as psychotic patients and the remaining 70
were non-psychotic.
Results: Content validity of the CPQ was confirmed by an expert panel of five senior psychiatrists, achiev-
ing an overall reliability in the range of 0.86–0.93. The FVPOD group and comparison group had signifi-
cantly different mean scores on all four subscales of the CPQ. In identifying psychotic cases, the 35-item
positive symptom subscale had high sensitivity (97%) and low specificity (30%) with a cutoff value of 8.
Due to the low specificity, patients identified as potential psychotic cases were referred for further clinical
evaluation.
Conclusion: Applicability of the CPQ was demonstrated by its high reliability and good ability to discrim-
inate between clinical patients and a comparison group. The 35-item positive symptom subscale can be
useful alone in general mental health settings for screening psychotic cases.
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Identifying the prodromal phase of psychosis is
crucial for early detection and early interven-
tion.1,2,3 Schizophrenia is a major psychotic dis-
order, but it has a gradual onset. The prodromal
state before the onset of frank psychotic symp-
toms allows opportunity for early detection and
clinical intervention. For this reason, much re-
search effort has been allocated to prodromal
states of chronic psychotic disorders, especially
schizophrenia. Schizophrenia is a chronic illness
with grave personal, family, and social costs. The
annual economic cost of schizophrenia in Taiwan
has been estimated as US$560 million.4,5 The high
medical costs of psychotic illnesses might be re-
duced by early detection and early intervention.
Thus, early detection and early intervention in
chronic psychotic disorders, particularly schizo-
phrenia, now ranks among the major research 
issues in psychiatry.3,6
In the 1990s, a long-standing interest in prodro-
mal schizophrenia symptoms led to attempts at
systematic detection of the prodromal phase. The
average length of the prodromal phase is between
2 and 5 years.3,7–9 During this phase, subjects ex-
perience substantial psychosocial impairments.
Common early clinical features include nonspe-
cific symptoms such as sleep disturbance, anxiety,
irritability, depression, poor concentration, and fa-
tigue, in addition to behavioral symptoms such as
deterioration in role functioning and social with-
drawal. Brief, often attenuated, episodes of positive
symptoms, such as perceptual abnormalities or
paranoia, develop later and herald the imminent
onset of psychosis.10,11
Currently, the field of detecting prodromal
states of psychosis is dominated by two main 
approaches. One is the Positive and Negative
Syndrome Scale, focusing on attenuated positive
symptoms, using instruments such as the Compre-
hensive Assessment of At-Risk Mental States, or
the Structured Interview of Prodromal Syndromes
(SIPS). The other approach, known as the Basic
Symptoms approach, is based on a detailed phe-
nomenological description of disturbances prior
to psychosis onset, using instruments such as the
Bonn Scale for the Assessment of Basic Symptoms,
or the Schizophrenia Prediction Instrument-Adult
version. Instruments for screening prodromal signs
include the screen for prodromal symptoms
(PROD-screen), the Prodromal Questionnaire
(PQ), the Youth Psychosis at Risk Questionnaire,
and SIPS screening. SIPS assessment of prodro-
mal diagnosis criteria at least once a week is the
current gold standard for detection of prodromal
signs.12–14
These screening instruments do not adequately
predict diagnosis because they are not systemati-
cally used in studies. Research has shown that
self-reporting of experiences can be reliable and
valid.15 Self-reporting can be a valuable aid to early
detection and early intervention in psychosis. The
PQ, a self-reporting instrument, has been shown
to have good concurrent validity, and appears very
promising as a simple and cost-effective way of
screening prodromal and previously undiagnosed
psychotic symptoms in a treatment-seeking pop-
ulation as well as the general adolescent and young
adult population aged 12–35.13,14 The original
authors formulated the PQ by merging original
items based on their own experience with some
items adapted from the Schizotypal Personality
Questionnaire16 and some probing questions
adapted from the SIPS.17
The PQ is a self-reporting questionnaire com-
prising 92 true/false items and takes approximately
20 minutes to complete the questionnaire. The 92
items can be divided into four major subscales:
(1) positive symptoms (e.g. unusual thinking and
perceptual abnormalities); (2) negative symptoms
(e.g. flat affect and social isolation); (3) disorgan-
ized symptoms (e.g. odd behavior); and (4) general
symptoms (e.g. depression and diminished role
functioning). The Cronbach’s α values are 0.92
for positive symptoms (45 items), 0.88 for nega-
tive symptoms (19 items), 0.79 for disorganized
symptoms (13 items), 0.85 for general symptoms
(15 items), and 0.96 for total scale (92 items).
The PQ positive symptom subscale correlates with
the corresponding SIPS scale for positive symptoms
(r = 0.60, p < 0.0001). This concurrent validity in-
dicates that the PQ can distinguish subjects with
prodromal or psychotic symptoms. The PQ also
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examines the preliminary psychometric properties
of subjects with suspected prodromal psychotic
symptoms.
We developed a Chinese version of the PQ
(CPQ) after obtaining permission from the orig-
inal PQ authors. The purpose of this study was 
to evaluate the reliability and validity of the CPQ
based on a sample of first-visit clients to a psy-
chiatric outpatient department (FVPOD) and 
a sample of healthy subjects as a comparison
group.
Methods
Study participants and setting
Subjects were first-visit patients recruited from
the outpatient department of psychiatry (patient
group designated herein by the acronym
FVPOD). Comparison group subjects having no
history of psychiatric disorder were recruited
from the student body of the School of Nursing.
All subjects in both groups were advised as to the
procedures in the study, and signed informed
consent forms. Subjects in the FVPOD group un-
derwent structured interviews to identify psy-
chotic syndrome. All subjects were then instructed
to complete the CPQ. There were initially 123
FVPOD subjects meeting eligibility criteria, but
23 did not complete the CPQ questionnaire, or
did not participate in structured interviews, and
were dropped from the study. The final FVPOD
group comprised 100 subjects. Thus, the comple-
tion rate was 81%.
The diagnostic criteria for psychotic syndrome
were based on the fourth edition of the Diagnosis
and Statistical Manual of Mental Disorders (DSM-
IV). Those applicable to the structured interview
were: presence of any delusions, hallucinations,
disorganized thought or unusual behavior includ-
ing catatonia symptoms. Criteria were applied ac-
cording to the sections in the Chinese version of the
Diagnostic Interview for Genetic Study (DIGS-C)
on mania/hypomania, alcohol abuse and depen-
dence, drug abuse and dependence, and psychosis.
The DIGS-C was translated and applied by Chen
and colleagues.18 The objective of the structured
interview screening was to exclude bipolar and
substance-use disorder, as well as to identify psy-
chotic symptoms of at least 1 week duration to
select a non-psychotic and therefore more homo-
geneous subsample of FVPOD subjects for this
exploration of CPQ applicability. Of the 100 sub-
jects in the FVPOD sample, all 15–30 years of age,
30 were identified positively under these psychotic
syndrome criteria, and the remaining 70 formed
the non-psychotic subsample. The 98 subjects in
the comparison group, 18–30 years of age, were
all nursing students without any evidence of psy-
chiatric disturbances.
Translation of the PQ
Using Brislin’s Revised Model,19,20 the PQ was
first translated into Mandarin Chinese with per-
mission from the authors.13 This translation, from
the original English to Chinese (traditional charac-
ters), was performed by two bilingual researchers
in our research team. The translation and the
original English PQ were then reviewed and the
translation was slightly amended by several psy-
chiatric professionals and a native Chinese speaker
who is fluent in English and holds a Master’s de-
gree in English from an American university. This
review resulted in the production of a second-
draft translation. The research team then consulted
five bilingual experts and five first-episode patients
diagnosed with schizophrenia, and slight revisions
were made based on these consultations, result-
ing in a third-draft translation. Two independent
bilingual researchers from outside our research
team subsequently back-translated the third-draft
Chinese version into English. An American lan-
guage teacher then tested the back-translation
against the original English PQ for equivalence
of meaning.
By these means, the original Chinese transla-
tions of the PQ questionnaire items were modified
to better correspond to the meaning of items in
the PQ. A lay panel was then asked to assess the
comprehensibility of the resulting Chinese ver-
sion, highlight errors, and suggest translation 
alternatives. The research team members then
S.C. Chiu, et al
650 J Formos Med Assoc | 2010 • Vol 109 • No 9
met to finalize the CPQ based on suggestions
from the lay panel. Some minor, final adjust-
ments to the Chinese text were made and tested
by the back-translation procedure until the back-
translated English items were found to be com-
pletely interchangeable with the original PQ items,
conceptually and linguistically. The Chinese text
of this resulting CPQ was then finalized by con-
sensus by the same panel of five senior psychia-
trists who established its content validity.
Instruments
The Chinese Health Questionnaire-12
The Chinese Health Questionnaire (CHQ) is a
30-item Chinese translation of the General Health
Questionnaire (GHQ) originally developed by
Goldberg et al,21 with substitution of 12 specially
designed, culturally-relevant items (CHQ-12). The
GHQ is a self-administered screening instrument
widely used in clinical settings and communities
to screen for minor psychiatric morbidity. The
CHQ-12 is a psychiatric screening instrument
developed by discriminate function analysis of
the 30-item CHQ. Each item specifically asks the
respondent to rate his or her health issues during
the preceding weeks on a scale of four levels:
“not at all”, “no more than usual”, “more than
usual”, and “a lot more than usual”. The possible
scores for the CHQ-12 range from 12 to 48. The
CHQ-12 has shown good internal consistency
across a range of different cross-sections of the
population of Taiwan [Cronbach’s α of 0.84 in a
broad sample recruited from residents of three
population centers differing on the rural/urban
scale (n = 1023); Cronbach’s α of 0.83 in a sample
of consecutive attendees for health screening at a
general hospital (n = 386)].22 The CHQ-12 has
been used to identify psychiatric factors including
somatic symptoms, depression, insomnia and
anxiety.23
Screening for psychosis using the DIGS-C instrument
Psychotic symptoms include delusions, hallucina-
tions, disorganized behavior, formal thought dis-
order, and catatonic behavior. The assessment of
psychotic symptoms was performed by interviewing
the subjects using the psychosis section of the
Chinese version of the DIGS-C. The DIGS, devel-
oped by the US National Institute of Mental
Health, is a poly-diagnostic interview instrument
widely used to assess psychotic disorders and their
spectrum conditions.24,25 With regard to the as-
sessment of psychotic symptoms, an inter-rater re-
liability of the Chinese version has been established
in a clinical schizophrenia sample (κ = 0.86).18
Procedures
The study proposal was approved by an internal
review board of the National Taiwan University
Hospital. All participants gave informed consent
and completed the CPQ and CHQ-12 question-
naires, and additionally provided demographic
data (age, gender, education and marital status).
FVPOD subjects underwent structured interviews
using the DIGS-C psychosis section and the sec-
tions of mania/hypomania, alcohol abuse and de-
pendence, drug abuse and dependence to assess
the presence of psychotic symptoms. The struc-
tured interviews were conducted by a specially
trained research assistant whose training included
familiarization with structured interviews and the
psychotic symptom items, as well as an evaluation
in a real case interview setting, achieving an inter-
rater reliability of kappa = 0.88 for assessment of
the presence of psychotic symptoms.
Exclusion criteria included: diagnoses of mania,
hypomania, or alcohol and substance dependence
or abuse, IQ ≤ 70, and major neurological disor-
ders. Twenty of the FVPOD participants received
the CPQ twice during a test-retest interval of
7–14 days.
Statistical analysis
The CPQ and CHQ-12 scores, together with para-
metric demographic data, were tested using Mann-
Whitney U test, t test, analysis of variance and post
hoc comparisons to examine differences among
the non-psychotic subsample, the psychotic sub-
sample, and the comparison group. Internal con-
sistency was examined by computing the reliability
coefficient (Cronbach’s α). Test-retest reliability
was examined by measure of agreement using
Chinese Prodromal Questionnaire
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kappa statistics between initial and retest data for
FVPOD subjects. Validity testing was performed
by comparing CPQ scores with CHQ-12 scores.
Receiver operating characteristic (ROC) analyses
were used to assess accuracy of the application of
the positive symptom subscale of CPQ for the as-
sessment of prodromal state against the diagno-
sis of psychotic state from structured interviews
using DIGS-C.
Results
Reliability of the CPQ
Using Cronbach’s α, the overall reliability coeffi-
cient for all participants of the CPQ was in the
range 0.86–0.93. Item-total correlations ranged
from 0.17 to 0.71. Thirteen items showed a low
item-total correlation, or item-to-item correlation
of less than 0.40, and Mann-Whitney U tests for
those 13 items found no significant difference
among the non-psychotic subsample, the psycho-
tic subsample, and the comparison group. Those
13 items could therefore be safely deleted with-
out effect on Cronbach’s α. Analysis therefore pro-
ceeded based on the remaining 79 items of the
CPQ. The 79 items were composed of positive
symptoms (35 items), negative symptoms (18
items), disorganized symptoms (12 items), and
general symptoms (14 items). All item-total cor-
relations were greater than 0.32. Mean scores of
the CPQ were significantly higher for the psy-
chotic subsample. Test-retest reliability among
the FVPOD group was indicated by kappa values
in the range 0.48–0.66 (n = 20).
The sample
The CPQ was administered to 100 FVPOD patients
and a comparison group of 98 university nursing
students without any psychiatric history. In the
FVPOD subjects, mean age was 22.8 ± 4.0 years,
51% were female, 94% unmarried, 55% college ed-
ucated. In the comparison group (n=98), age range
was 21.2±3.9 years, 87.8% were female, 95.9% un-
married, 100% college educated. There were signif-
icant differences in gender and education between
the FVPOD and comparison group, but no sig-
nificant differences in age or marital status.
The criteria for psychotic status in the FVPOD
group were based on the DSM-IV, using data 
collected in structured interviews using DIGS-C.
The demographic profile of the FVPOD showed no
significant differences between the psychotic and
non-psychotic subsamples, in gender, marital sta-
tus, educational attainment, or age. There were
significant differences in gender and education be-
tween the psychotic subsample and the compari-
son group, but no significant differences in age or
marital status. In the psychotic subsample (n=30),
the mean age was 23.5 ± 4.4 years, 56.7% were
female, 90% unmarried, and 46.6% college edu-
cated. In the non-psychotic subsample (n = 70),
the mean age was 22.5 ± 3.7, 48.6% were female,
95.7% unmarried, and 58.6% were college 
educated.
Comparison of subscale scores of CPQ
between study groups
Table 1 demonstrates the significant difference in
mean score on the CPQ positive symptom sub-
scale between the psychotic and non-psychotic
subsamples (p < 0.001), with no significant differ-
ences observed on the other three subscales. There
were also significant differences in the means of
all four subscales of the CPQ between the whole
FVPOD group and the comparison group (p <
0.001, data not shown). As would be expected,
comparison subjects reported a low level of symp-
toms. Tables 2 and 3 show that both the psychotic
and non-psychotic subsamples of the FVPOD dif-
fered significantly from the comparison group on
all four subscale scores of the CPQ.
Among FVPOD subjects, the CPQ total score
and positive symptom subscale score were sig-
nificantly correlated with the CHQ-12 (CPQ,
r = 0.839, p < 0.001; PS, r = 0.755, p < 0.001). The
FVPOD group and the healthy comparison group
showed a significant difference in their mean
CHQ-12 scores, but there was no significant dif-
ference between the non-psychotic and psychotic
subsamples of the FVPOD in the CHQ-12 scores
(Tables 1 and 2).
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Sensitivity and specificity testing
The positive symptoms subscale of the CPQ sensi-
tively identified the FVPOD subjects with psy-
chotic symptoms. The CPQ had a sensitivity of
97%, using a cutoff value of 8 to discriminate
psychosis, but had a poor specificity of 30%
(Table 4). When the cutoff level is set at or above
11, the positive symptoms subscale produces 80%
Table 1. Comparison of mean scores of four subscales of the Chinese version of Prodromal Questionnaire
and the Chinese Health Questionnaire-12 between non-psychosis and psychosis groups of first visit
clients of psychiatric outpatients
Variable Non-psychosis (n = 70) Psychosis (n = 30) p
CPQ
Positive symptoms
Mean ± SD* 12.9 ± 7.0 21.3 ± 9.5 0.00‡
Mean range† 43.0 68.0 0.00‡
Negative symptoms
Mean ± SD* 11.0 ± 4.8 11.3 ± 5.5 0.73
Mean range† 49.5 52.8 0.60
Disorganized symptoms
Mean ± SD* 5.4 ± 3.2 6.6 ± 3.5 0.09
Mean range† 47.5 57.2 0.13
General symptoms
Mean ± SD* 9.0 ± 3.4 9.4 ± 4.0 0.64
Mean range† 49.1 53.8 0.45
CHQ-12
Mean ± SD* 32.6 ± 7.5 33.8 ± 7.5 0.45
Mean range† 48.3 54.1 0.36
*t test; †Mann-Whitney U test; ‡p < 0.001 (two-tailed). CPQ = The Chinese version of Prodromal Questionnaire; CHQ-12 = the Chinese
health questionnaire-12; SD = standard deviation.
Table 2. Comparison of mean scores of four subscales of the Chinese version of Prodromal Questionnaire
and the Chinese Health Questionnaire-12 between psychosis and comparison
Variable Non-psychosis (n = 30) Comparison (n = 98) p
CPQ
Positive symptoms
Mean ± SD* 21.3 ± 9.5 5.4 ± 5.1 0.00‡
Mean range† 106.8 51.6 0.00‡
Negative symptoms
Mean ± SD* 11.3 ± 5.5 4.5 ± 3.7 0.00‡
Mean range† 97.3 54.5 0.00‡
Disorganized symptoms
Mean ± SD* 6.6 ± 3.5 1.6 ± 2.1 0.00‡
Mean range† 105.3 52.1 0.00‡
General symptoms
Mean ± SD* 9.4 ± 4.0 3.8 ± 3.3 0.00‡
Mean range† 99.0 53.9 0.00‡
CHQ-12
Mean ± SD* 33.8 ± 7.5 22.6 ± 5.3 0.00‡
Mean range† 101.3 54.9 0.00‡
*t test; †Mann-Whitney U test; ‡p < 0.001 (two-tailed). CPQ = The Chinese version of Prodromal Questionnaire; CHQ-12 = the Chinese
health questionnaire-12; SD = standard deviation.
Chinese Prodromal Questionnaire
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sensitivity and 44% specificity. Assessing the 35-
item positive symptom subscale of CPQ for clas-
sification accuracy of psychotic syndrome versus
non-psychotic subsample of the FVPOD sub-
jects, the area under the ROC curve was signifi-
cant (Figure).
Discussion
The present study aimed to evaluate the validity
and reliability of the CPQ for identifying prodro-
mal states of psychosis. The high correlation of
CPQ total scores with CHQ-12 scores suggests
that both instruments are valid for revealing
psychopathology in a general population. CPQ
results showed a high degree of internal consis-
tency (Cronbach’s α in the range 0.86–0.93) and
good convergent validity (r = 0.839). FVPOD
subjects, who were treatment-seeking cases, had
significantly higher CPQ scale scores than sub-
jects in the comparison group. This was also true
of CHQ-12 scores. But the CPQ proved more ef-
fective than the CHQ-12 in discriminating be-
tween psychotic and non-psychotic groups. The
CHQ-12 did not discriminate between the psy-
chotic and non-psychotic subsamples of the
FVPOD. The CPQ produced significantly higher
scores in the psychotic subsample than in the
non-psychotic subsample (or in the comparison
Table 3. Comparison of the mean scores of four subscales of the Chinese version of Prodromal Questionnaire
among three study groups using analysis of variance statistics and post hoc testing
Variable
Non-psychosis Psychosis Comparison 
F p
Post hoc
(n = 70) (n = 30) (n = 98) 1‡ 2§ 3
Positive symptoms 12.9 ± 7.0 21.3 ± 9.5 5.4 ± 5.1 73.44 0.000† 0.000† 0.000† 0.000†
Negative symptoms 11.0 ± 4.8 11.3 ± 5.5 4.5 ± 3.7 55.29 0.000† 0.926 0.000† 0.000†
Disorganized symptoms 5.4 ± 3.2 6.6 ± 3.5 1.6 ± 2.1 60.46 0.000† 0.122 0.000† 0.000†
General symptoms 9.0 ± 3.4 9.4 ± 4.0 3.8 ± 3.3 60.68 0.000† 0.887 0.000† 0.000†
Global symptoms 38.2 ± 16.4 48.6 ± 20.2 15.2 ± 12.6 78.76 0.000† 0.008* 0.000† 0.000†
*p < 0.01 (two-tailed test); †p < 0.001 (two-tailed test); ‡Non-phychosis group versus psychosis group; §non-phychosis group versus
comparison group; psychosis group versus comparison group.
Table 4. The validity of different cutting off points of the positive symptom subscale of the Chinese version
of Prodromal Questionnaire in identifying prodromal state of psychosis identified by using DIGS-C
as golden criteria in 100 first visit outpatients
Cut-off score Prevalence Sensitivity Specificity Positive predictive value Negative predictive value
6 0.3 1.00 0.19 0.23 1.00
7 0.3 1.00 0.26 0.24 1.00
8 0.3 0.97 0.30 0.37 0.95
9 0.3 0.90 0.36 0.38 0.89
10 0.3 0.80 0.37 0.35 0.81
11 0.3 0.80 0.44 0.38 0.84
12 0.3 0.73 0.47 0.37 0.80
13 0.3 0.73 0.51 0.39 0.82
14 0.3 0.70 0.53 0.39 0.80
15 0.3 0.70 0.57 0.41 0.82
16 0.3 0.70 0.61 0.44 0.83
17 0.3 0.67 0.64 0.44 0.82
18 0.3 0.67 0.67 0.47 0.82
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group). Indeed, the 35-item positive symptom
subscale of the CPQ alone can distinguish be-
tween psychotic and non-psychotic subsamples
of the FVPOD group.
Thirteen of the 92 items of the CPQ were found
to have a low item-total correlation (r < 0.40) 
or low item-to-item correlation, with Mann-
Whitney U tests showing no statistical significance.
Based on this result, we suggest that these 13 items
be deleted from the CPQ, producing a 79-item
questionnaire that is equally as effective as the
92-item questionnaire.
The sensitivity for identifying psychotic cases
of the 35-item positive symptom subscale of 
the CPQ, with a cutoff point of eight positive
symptoms, is high (97%), but the specificity is
only 30%. Thus we suggest that the 35-item 
positive symptom subscale of the CPQ is a good
sensitive tool in screening for psychotic cases.
The low sensitivity, however, clearly points to the
need for expert psychiatric evaluation of cases
screened as positive to determine whether there
is actual psychotic syndrome. The clinical appli-
cation of CPQ in a treatment-seeking population
is justified and it can be helpful in identifying
psychotic prodrome cases for early intervention.
Currently, SIPS is commonly used to diagnose
prodromal psychosis. The SIPS diagnosis of 
prodromal psychosis is driven by the presence of
positive psychotic symptoms. Around 40–54%
of these prodromal cases progress to full psycho-
sis.3,11,17 Loewy et al reported that the posi-
tive diagnosis of prodromal state of psychosis 
was significantly associated with the positive
symptom subscale of PQ.13 Our results corrobo-
rate Loewy’s finding and extend it to the CPQ.
We suggest that these results justify application
of the CPQ in screening for prodromal 
psychosis.
The present study included a comparison
group of participants without past psychiatric
history. For reasons of practical convenience, col-
lege students enrolled in schools of nursing were
recruited for the comparison group. That choice,
however, contributed to significant differences in
gender and education between our comparison
and experimental groups. We recognize this as a
sampling limitation of the study. However, the
gender and education bias may not seriously in-
fluence our results, as the comparison group was
comprised of subjects without any psychiatric
history.
In summary, the present study examines the
psychometric properties of the CPQ in a treat-
ment-seeking sample and a comparison sample.
Results suggest that the CPQ is a psychomet-
rically sound screening tool for differentiating
clinical subjects from groups without psychiatric
disturbances. The 35-item positive symptom sub-
scale of the CPQ can be used as a separate instru-
ment to screen FVPOD patients for psychosis.
This 35-item positive symptom questionnaire
can be easily self-administered to patients and is
a sensitive tool for early detection of psychosis in
general mental health settings. Its downside is its
low specificity. We therefore suggest that all sub-
jects who are screened as potentially psychotic
need to receive diagnostic evaluation by a clini-
cal psychiatrist.
A listing of the 35 items of the positive symp-
tom subscale of the CPQ is available from the
corresponding author upon request.
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Figure. The receiver operating characteristic curve for as-
sessing identification of psychosis by the Chinese version
of Prodromal Questionnaire positive symptom subscale as
compared to identification of psychosis by DIGS-C.
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